ACTIVATE LIFE
Through IMPAKT™ – Immune Modulating Precision Allosteric Kinase Therapy – ImmVue is building a next-generation platform of allosteric small molecules designed to tune intracellular signaling in T cells
The old way is brute force.
The new way is precision.
ImmVue programs are built on the IMPAKT™ platform, designed to precisely tune intracellular immune signaling
Unlike traditional immune therapies that push the immune system broadly, IMPAKT molecules act at critical intracellular control points, allowing immune activity to be shaped with greater precision
One platform.
Two lead programs.
IMPAKT is our machine learning based discovery platform for identification of allosteric small molecules that modulate immune kinases at critical signaling junctions enabling adaptive, bidirectional immune control
World-class Leadership
Our team has built advanced therapies across multiple successful biotech programs and global pharmaceutical collaborations
Contact
We’re actively engaging collaborators, investors, and talent passionate about shaping the future of immune therapeutics
info@immvue.com
Partner with Us